Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Metastasis From Solid Tumors”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableStudy completedNCT00898079
What this trial is testing

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

Who this might be right for
Acute Undifferentiated LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeChildhood Acute Lymphoblastic Leukemia+11 more
Children's Oncology Group 2,545
Large-scale testing (Phase 3)Study completedNCT04812509
What this trial is testing

Efficacy and Safety of MW032 and Xgeva® in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Mabwell (Shanghai) Bioscience Co., Ltd. 708
Early research (Phase 1)Study completedNCT02517918
What this trial is testing

Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma

Who this might be right for
Solid TumorOsteosarcoma
Institut Bergonié 23
Early research (Phase 1)UnknownNCT04494373
What this trial is testing

Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy Adults

Who this might be right for
Bone Metastasis From Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd. 154
Not applicableLooking for participantsNCT01050504
What this trial is testing

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Who this might be right for
Localized Renal Pelvis and Ureter Urothelial CarcinomaMalignant Solid NeoplasmMetastatic Malignant Neoplasm in the Bone+8 more
University of Washington 1,500
Large-scale testing (Phase 3)UnknownNCT04859569
What this trial is testing

Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases From Solid Tumors
Luye Pharma Group Ltd. 850
Early research (Phase 1)Looking for participantsNCT06069570
What this trial is testing

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors
Kiromic BioPharma Inc. 48
Large-scale testing (Phase 3)UnknownNCT04550949
What this trial is testing

To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases
Qilu Pharmaceutical Co., Ltd. 700
Not applicableLooking for participantsNCT07112989
What this trial is testing

Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors

Who this might be right for
Bone and Soft Tissue TumorsBone Metastases From Solid TumorsLung Metastases
Istituto Ortopedico Rizzoli 125
Early research (Phase 1)Study completedNCT04630522
What this trial is testing

Efficacy and Safety of JMT103 in Patients With Bone Metastases From Solid Tumors

Who this might be right for
Bone Metastases From Solid Tumors
Shanghai JMT-Bio Inc. 295
Large-scale testing (Phase 3)Not Yet RecruitingNCT06221072
What this trial is testing

Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic Acid

Who this might be right for
Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors
Shanghai JMT-Bio Inc. 1,360
Testing effectiveness (Phase 2)Looking for participantsNCT07028268
What this trial is testing

A Trial of SHR-2017 Injection in Patients With Bone Metastases From Solid Tumors

Who this might be right for
For Prevention of Bone Events in Patients With Bone Metastases From Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 210
Not applicableWithdrawnNCT00900120
What this trial is testing

Collecting and Storing Blood Samples From Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT01920568
What this trial is testing

Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Fractures, Bone
GlaxoSmithKline 487
Not applicableEnded earlyNCT02718404
What this trial is testing

3 Tesla Magnetic Resonance Guided High Intensity Focused Ultrasound in the Treatment of Pain From Bone Metastases of Solid Tumors

Who this might be right for
Solid Tumors
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 12
Testing effectiveness (Phase 2)Study completedNCT00712712
What this trial is testing

Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer

Who this might be right for
Metastatic CancerPainUnspecified Adult Solid Tumor, Protocol Specific
Institut Bergonié 78